82 results on '"de Castro, J."'
Search Results
2. Deceased donor kidney procurement: Systematic review of the surgical technique
3. Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy
4. Laparoscopic nephron sparing surgery and radical nephrectomy in cT1 renal tumors. Comparative analysis of complications and survival
5. Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC—a systematic review and meta-analysis
6. Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
7. Biomimetic and cell-based nanocarriers – New strategies for brain tumor targeting
8. Comparison between laparoscopic and open prostatectomy: Oncological progression analysis
9. Genomic profiling in non-small-cell lung cancer in young patients. A systematic review
10. Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence
11. Analysis of recurrence trends according to risk groups after renal cancer nephrectomy
12. Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy
13. Influence of venous tumour extension on local and remote recurrence of stage pT3a pN0 cM0 kidney tumours
14. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
15. Effectiveness of the “cognitive” biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy
16. Postsurgical complications in patients with renal tumors with venous thrombosis treated with surgery
17. Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
18. Prognostic Potential of Candidate miRNAs in Lung Cancer: Insights from Tissue and Liquid Biopsies
19. Glioma Patient Management: Utilizing MGMT Methylation in Extracellular Vesicle-Based Liquid Biopsy
20. Size-dependent reinforcement of composite rubbers
21. Recomendaciones para el diagnóstico radiológico y la valoración de la respuesta terapéutica en el cáncer de pulmón. Consenso nacional de la Sociedad Española de Radiología Médica y la Sociedad Española de Oncología Médica
22. EP.13A.05 Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
23. P3.08E.04 TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM & NADIM II Trials
24. P1.13A.11 Patterns of Disease Progression after Atezolizumab Plus Chemotherapy in ES-SCLC: Exploratory Analysis from IMfirst Study
25. Conservative treatment of renal cell carcinoma in kidney transplantation
26. P088 - Renal tumors with left renal vein tumoral thrombosis. Is Preoperative Renal Artery Embolization (PRAE) helpful?
27. Variation of quality of life in patients with obstructive sleep apnea hipopnea syndrome after treatment with mandibular advance device
28. VP3-2021: A randomized phase II study of second-line osimertinib (Osi) and bevacizumab (Bev) versus Osi in advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) and T790M mutations (mt): Results from the ETOP BOOSTER trial
29. P267 - Quality of life in patients with Non-Muscle Invasive Bladder Cancer (NMIBC) subjected to intravesical instillations with BCG induction
30. P037 - Risk of detecting prostate cancer based on the PSAD and PIRADS lesions in MRI in patients with a negative previous biopsy.
31. 16MO Clinical impact of plasma EGFR analysis: Results from the ETOP-BOOSTER randomized phase II trial
32. PP01.17 Sotorasib in Advanced KRAS p.G12C–Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)
33. EE495 Cost-Effectiveness Analysis of Adjuvant Atezolizumab Versus Best Supportive Care in the Treatment of Patients With Resectable Early-Stage Non-Small Cell Lung Cancer and PD-L1≥50% Expression
34. P032 - Prostate rebiopsy in patients with a negative previous biopsy and MRI. When should it be done?
35. 989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
36. Estudio de la validez de un equipo de poligrafía respiratoria (BREAS SC–20) para el diagnóstico del síndrome de apneas-hipopneas durante el sueño
37. New insights in β-tubulin sequence analysis in non-small cell lung cancer
38. Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy
39. P013 - Age. An exponential risk factor for prostate cancer
40. P115 - Development of a predictive model for optimizing the selection of patients for second transurethral resection bladder (TURB)
41. MA14.02 RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
42. OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy
43. OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
44. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study
45. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial
46. PCN90 Economic IMPACT of the NSCLC Molecular Diagnosis in Spain: A Retrospective Analysis of Healthcare Resources Use and Associated Costs from the LUNG-One Study
47. P112 - Risk model- recurrence risk groups for patients with localised renal cell carcinoma
48. P026 - Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy
49. P2.09-11 TMB Estimated with Targeted NGS in Early Stage Squamous Cell Carcinoma: Correlation with PD-L1 Expression and Lymphocyte Density
50. P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.